that, although population-wide data are scanty and imprecise for the United States, the available information suggests that the mean daily sodium intake is 2 to 4 g. There are regional and racial differences-interestingly, the most noteworthy racial difference in electrolyte intake is the markedly lower potassium intake of black Americans. Professor He pointed out that most sodium is derived from processed foods, with baked goods, particularly breads, the largest single contributor. Crosssectional data, over time, suggest a slowly increasing level of sodium intake, probably related to increased consumption of prepared foods. There is also a strong body of evidence supporting the relationship of sodium to blood pressure-although several longer-term studies have shown a weaker relationship, possibly a result of methodological issues related to the imprecise measurement of both individual salt intake and individual blood pressure levels.
Data from China, presented by Zhiquan Liu, revealed that sodium intake is generally twice that in the United States but varies widely by geography, ethnicity, and habitat. Those in the north and northwestern regions, which are colder, consume substantially more than the national average of 4-5 g per day. The amount of salt eaten has not changed dramatically since the early 1980s, with residents of rural areas eating more than city dwellers. Interestingly, although consumption of soy sauce-a major contributor of sodium-has declined considerably in the north, it has not been accompanied by a change in sodium intake. One explanation may be the fact that salt-pickled vegetables, a leading The idea for a workshop focused on sodium and health was generated by the editors of the American Journal of Hypertension and the Chinese Journal of Hypertension as part of their emerging collaboration. It reflects a belief that scientists and clinicians interested in blood pressure and its related conditions would profit from more effective communication and interaction. Salt was chosen as a central topic because of its multiple physiological and pathological effects, its importance to human health, its role in elevating blood pressure, the unresolved scientific issues, and the absence of an agreed public health response regarding dietary sodium. In addition, much current clinical and population research has begun to shed light on how the interaction of genetics, environment, and diet determines the impact of sodium intake on human health and disease. Surprisingly, given the often passionate professional interest, there has been no regular forum dedicated to an exchange of new knowledge and current research findings. The biomedical literature provides strong evidence that investigators around the world are generating important new findings that increase understanding of how dietary sodium may relate to both health and disease. Given the widely shared need and interest, the workshop's organizers hope that the experience in Xi'an will lead to the appearance of regular working meetings on sodium and human disease on the international scientific schedule. The ultimate goal is for this scientific discourse to lead to evidence-based programs for population salt consumption that will contribute to the betterment of human health.
SUMMARY
source of salt intake in these regions, are consumed with most meals. In general, there is a strong correlation between sodium intake and blood pressure in different regions and populations. One unusual and unexplained exception is the fishing islands of Zhoushan, whose inhabitants have an estimated daily sodium intake of 7 g-roughly 30% greater than the average consumption in China-yet have relatively low blood pressure. Potassium intake, ascertained simultaneously, was 50 mEq/day (about 30 mEq/day less than in other parts of the country), resulting in a sodium:potassium ratio of 6.2.
The second session was dedicated to ongoing interventional research on various dietary approaches to reducing blood pressure. Yangfeng Wu presented results from the China Salt Substitute Study-1, which compared the use of a salt substitute (composed of 68% sodium, 22% potassium chloride, and 10% magnesium sulfate) with that of regular (99% sodium) sodium chloride in 608 older (mean age 60) residents from six sites in rural northern China. A reduction in both peripheral (7.4 mm Hg; P = 0.01) and central systolic blood pressure (6.9 mm Hg; P = 0.01) with associated declines in central pulse pressure and reflection time was observed in those who used the salt substitute, with no changes in diastolic blood pressure. Little ability to detect taste differences caused by the modified sodium and potassium levels was demonstrated, suggesting that the intervention might be fairly well tolerated.
A novel salt substitute, developed jointly by the Pingjin Hospital, the Medical College of the Chinese People's Armed Police Forces, and Tianjin Kaifu S&T Development, was discussed by Xin Zhou. The formulation contained only 65% sodium, the rest replaced by potassium, calcium salts, and folic acid. Fed to rats over a short period of time, it reduced blood pressure and collagen deposition in the heart and kidneys. In a randomized clinical trial, 6 months of consumption of the substitute produced a fall in urinary sodium and an increase in potassium and calcium, and both systolic and diastolic pressure declined. Discussants emphasized the need to further understand the relative roles of sodium and potassium in blood pressure modulation.
A complementary study, presented by Jianjun Mu of Xi'an Jiaotong University, involved a 2-year prospective dietary intervention in which each of 325 adolescents with high blood pressure (124/75 mm Hg) was randomly allocated to one of three groups: a control group, a restricted-sodium group aiming to consume 50 mmol of sodium per day, and a group advised to add 10 mmol each of potassium and calcium while consuming their regular level of sodium. In this setting, with most of the food consumed being prepared in the home, the goals for electrolyte intake were largely achieved. At 2 years, the sodium intake of the restricted-intake group had fallen substantially. In the group who added potassium and calcium, sodium intake was equal to that of the control group, and potassium intake was higher than in controls. Blood pressure fell significantly and similarly in the two intervention groups compared with the controls.
Taken together, these two studies support the notion that-at least in northern China, where sodium intake is high and potassium intake low-adding potassium may have the same effect on BP that can be produced by reducing sodium intake. The authors suggest that supplementation with calcium and potassium may be more feasible for residents of northern China than attempts to limit sodium intake. It is also possible that additive effects achieved by moderate changes in both sodium and potassium intake would be best tolerated and produce the largest reductions in blood pressure. Further studies could better define the separate and combined effects of these strategies on blood pressure. Dongfeng Gu presented results from a US-Chinese collaboration that assessed blood pressure effects in short-term (7 days) feeding studies among nearly 2,000 rural residents of northern China. Three diets were compared-low sodium (51 mmol per day), high sodium (307 mmol per day), and high sodium plus a daily supplement of 60 mmol of potassium. The response of blood pressure to the first two diets was large, and in the expected directions. The effect on blood pressure of the highsodium diet supplemented with potassium was similar to that produced by the low-sodium diet.
In a later session, Bruce Neal of Sydney, Australia, made the epidemiological case for population-wide sodium restriction. Noting that 1-2 g of sodium per day is adequate to maintain good health, and that an adult blood pressure of 115/75 mm Hg is optimal, he presented data to show that reduction of sodium to that level would have a powerful effect on population blood pressure, which would be sustained and thus reduce the burden of elevated blood pressure as the population ages. The ability of sodium restriction to lower average pressure is well established. Neal argued that this could be achieved on a population basis at low cost via industrial intervention, which would be more effective than attempts to influence individual behavior. Extrapolating from antihypertension drug treatment trials, he contended that the achieved reduction in blood pressure would translate into avoided strokes, heart attacks, and heart failure-the leading causes of death and disability worldwide. He suggested that this might reduce mortality even more than can be achieved by smoking cessation.
Michael Alderman of Bronx, NY, discussed evidence linking actual health effects to reduced sodium intake. The results of randomized clinical trials have demonstrated that reduced sodium has multiple effects in addition to lowering blood pressure, including activation of the renin-angiotensin system (RAS) and the sympathetic nervous system as well as reduction of insulin sensitivity. Unfortunately, no studies have addressed the "health" effect, i.e., the sum total of these proven individual effects. Lacking randomized trials, a large body of observational studies provides hypothesis-generating information. Overall, the results of these studies have been inconsistent and inconclusive. The positive associations occurred primarily in communities with "high" (≥5 g of sodium per 24 hours) salt intake, and the inverse relation dominated in those with "moderate" (2-4 g of sodium per 24 hours) salt intake. Taken together, these data best fit a J-shaped curvilinear relationship between sodium intake and mortality, with the optimal point at about 2-3 g of sodium per day. A spirited discussion revealed polarized views, with both sides agreeing only that more definitive data would be ideal. Ultimately the parties could not even agree on whether there was yet sufficient data to take action.
Salt sensitivity was the topic of three presentations. Jens Titze, from Erlangen, Germany, reviewed the physiology of renal regulation of extracellular volume through a servocontrol mechanism that modulates sodium balance. He also noted the difficulty of assessing sodium sensitivity through intravenous sodium loading and restriction combined with furosemide administration, a process that involves 24-hour urine collection. As a result, rigorous identification of sensitivity is generally not possible, and clinical studies rely on the blood pressure effect of dietary salt restriction. Meta-analyses have yielded results that differ by only 1 or 2 mm Hg and yet have led authors to opposite conclusions about the wisdom of population-wide sodium restriction. Moreover, while investigating the role of extracellular sodium content and its renal regulation has been a productive method for elucidating vascular effects, it may not explain all the effects of a varied sodium diet. Titze posed the intriguing hypothesis that sodium may not be limited to the extracellular compartment but may also be stored in interstitial space as hypertonic solution. This may offer another means by which to explain responses to variation in dietary sodium.
The clinical characteristics of individuals with salt sensitivity have been defined in a series of studies by Zhiquan Liu in northern China. Prevalence, defined clinically by blood pressure response, varied from about 30 to 60% among adults, with children having the same wide range but at a slightly lower level. Salt-sensitive (SS) subjects had several distinguishing characteristics, including higher erythrocyte sodium levels, an accelerated erythrocyte sodium-lithium countertransport rate, decreased Na/Kase activity, decreased plasma renin suppression in response to sodium loading, and increased insulin resistance after salt loading. Clinically, SS subjects have reduced nocturnal blood pressure dipping and earlier appearance of target-organ damage. These findings have led Professor Liu to contend that salt sensitivity defines a distinct subset of hypertensive patients.
James Hixson of Houston, Texas, presented data from GenSalt-Genetic Epidemiology Network of Salt Sensitivity, a Chinese-US collaborative undertaking-linking single-nucleotide polymorphism (SNP) genotyping at candidate loci to components of metabolic pathways involved in renal handling of sodium. Thus, genes associated with components of the RAS were studied. Significant associations were found for SNPs in the angiotensin receptor type 1 and the renin-binding areas along with blood pressure response to low-sodium interventions. These variations in genes related to the RAS pathway are known to affect blood pressure, and they are common. Professor Hixson cautioned, however, that associations found in genetic analyses in different populations are likely to be inconsistent owing to modest effect sizes of SNPs linked to particular phenotypes.
In another example of international collaboration, Zhongmin Tain presented data generated by investigators at Xi'an Jaiotong University and the Medical College of Wisconsin. The Dahl SS rat has long been the standard for study of salt sensitivity. In an effort to provide an appropriate control for the animals, the consomic SS-13BN rat was developed by substituting a Brown Norway chromosome for chromosome 13 in the Dahl rat. This genetic transformation significantly reduced sodium sensitivity. The investigators were then able to detect four proteins encoded on chromosome 13 that might explain the salt sensitivity. One particular protein, fumarase, was found to have a single amino acid difference between the SS rat and the consomic rat. These findings suggest a path to understanding, on a molecular basis, the cause of salt sensitivity.
The final session of the meeting was devoted to assessing vascular effects beyond blood pressure that are influenced by variations in dietary sodium. Trefor Morgan focused on the interaction of sodium intake with the RAS. He noted that a highsalt diet may reverse the adverse effects associated with angiotensin II deficiency. In some ways, the effects of high sodium are similar to those caused by high levels of angiotensin II associated with an activated RAS. Thus, both cause left ventricular hypertrophy (LVH), cardiac fibrosis, endothelial dysfunction, vascular stillness, proteinuria, and renal dysfunction. Either blockade of the RAS or a low-salt diet can reverse or reduce proteinuria in diabetic subjects. Importantly, potassium can also reverse many of these adverse RAS-related effects. Morgan advocated both an increase in potassium intake and a reduction in sodium intake to achieve maximum cardiovascular disease prevention, but recognized the difficulty of achieving this goal on a population-wide basis without a centralized implementation strategy led by a coalition of industry and government.
Yan Liu of Xi'an Jiaotong University described her clinical studies to detect effects of sodium intake on left ventricular mass and erythrocyte sodium content in hypertensive and normotensive subjects. SS subjects, whether hypertensive or normotensive, were more likely than non-salt-sensitive (NSS) subjects to experience both LVH and greater LV relaxation impairment. Salt loading increased erythrocyte sodium content to a greater extent in SS subjects than in NSS subjects. Regression analysis showed SUMMARY mated by direct biopsies. These unique data-albeit collected in a small, unique sample, and in the absence of a control groupshould provide much valuable information on the relationship of sodium intake to changes in body sodium content and their overall physiological effects. Dr. Rakova indicated that the study would begin in mid-2009.
Conclusion
This brief summary provides clear evidence of the breadth of the presentations. However, absent an ability to capture the depth and excitement of the discussion surrounding the presentations, it is not possible to convey the enthusiasm and energy generated in this forum. Perhaps the most acceptable generalization that participants could apply was that a gap remains between what we know about sodium and human health and what we would like to know. There is apparent uncertainty about the prevalence of salt sensitivity and how to measure it, its genetics, and how such knowledge can be used to promote health and prevent disease. The critical public health question is whether limitation of sodium intake should be commenced on the basis of the existing evidence base or should be delayed until further data are available. There was no clear consensus about this, although there was some agreement that such intervention would be unlikely to cause harm to those eating very high levels of salt, and that it is these individuals who would be most likely to benefit. Because of the potential for widespread health effects, the need for definitive large-scale scientific research projects with mortality and morbidity end points and robust randomized designs was highlighted.
Our meeting began with a reminder that 2,500 years ago Chinese scholars recognized a link between dietary sodium, cardiovascular structure, and human health. Although much has been learned since then, much remains unresolved. In that spirit, all participants agreed that this workshop should be seen as only the first of what should be an annual event where scholars can meet, present, discuss issues linked to salt, and, as was the case with this meeting, return to their work with fresh ideas and renewed energy. that erythrocyte sodium content is an independent predictor of LVH. Thus, increased erythrocyte sodium content may be a marker for LVH, particularly in SS subjects.
In a series of interrelated animal, bench, and human studies, Huasheng Liu, also of Xi'an Jiaotong University, studied vascular remodeling in SS and NSS settings. She found that a low salt intake decreased collagen concentration in the thoracic aorta of spontaneously hypertensive rats. In vitro studies of umbilical vein endothelial cells revealed that the gene expression profile of endothelial growth factor (EGF) receptor and platelet-derived growth factor (PDGF) receptor rMNA were upregulated in a high-sodium medium compared with a low-sodium one. In the setting of a usual sodium diet, the carotid artery elasticity in normotensive SS subjects exceeded that in NSS normotensive subjects. However, in SS subjects, in contrast with normotensive NSS subjects, a high-salt diet markedly reduced carotid elasticity, and this persisted for 5 days after reverting to a restricted sodium intake. Regression analysis revealed that EGF and PDGF both contribute independently to arterial-wall stiffness in SS normotensive subjects. These data further support the blood pressure-independent vascular effects produced by increasing sodium intake. Natalia Rakova, of the State Scientific Center of the Russian Federation, Institute of Biomedical Problems, in Moscow, described a unique opportunity to precisely explore the effects of varied sodium intake in a physiologically controlled environment. Rakova pointed out the difference between "efficacy" (the level of success achieved when an intervention is perfectly applied) and "effectiveness" (that achieved in less perfect, realworld settings) to explain continuing uncertainty about the real effects of salt reduction. Six international astronauts will spend 105 days in a simulated land-based spacecraft. The environment, including dietary intake, will be controlled. All intake and excretion will be monitored. All subjects will follow a diet initially containing 12 g of salt per day, which after 4 weeks will gradually decrease to 6 g. Blood pressure will be measured twice daily, and there will be intermittent 24-hour recordings. Body-fluid composition will be monitored and skin electrolyte content esti-
